Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Context Therapeutics Inc.
BioNTech SE
Massive Bio, Inc.
BioNTech SE
Seagen Inc.
Astellas Pharma Inc
DxTerity Diagnostics
Power Life Sciences Inc.
Endocyte
SpeciCare
Celgene
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
INSYS Therapeutics Inc
Alaunos Therapeutics